Share

Abbott, ADA Launch Community Initiative to Advance Access to Diabetes Care and Technology

Last November, Abbott and the American Diabetes Association (ADA) announced the launch of their first joint community health partnership. The community initiative, which is the first program under the ADA’s Health Equity Now platform, will launch in Columbus, Ohio, and be conducted in partnership with the National Center for Urban Solutions (NCUS), a Columbus-based organization...
Share

High Altitude Exercise Could Increase Hypoglycemia Risk in People with Diabetes

People with diabetes may need to monitor their blood sugar more closely when doing high-altitude activities such as hiking or skiing, according to a small study published in the Society’s Journal of Clinical Endocrinology & Metabolism. Doctors often recommend exercise for people with diabetes as it has many benefits. It can improve heart health, insulin sensitivity, and quality of life. However, exercise can also cause hypoglycemia (dangerously low blood sugar) in people with diabetes during and after a workout. If...
Share

New Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in New Studies

Positive preliminary results of an ongoing, first-in-human Phase 1/2 study demonstrating that stem cell-derived therapy can produce insulin in people with severe type 1 diabetes were published today in Cell Stem Cell and Cell Reports Medicine. “The data from these papers represent a significant scientific advance,” said Cell Reports Medicine study lead author James Shapiro, MD PhD, Canada...
Share

The Highest Rates of Severe Hypoglycemia Crises Are in Patients with Diabetes and End-Stage Kidney Disease, Study Finds

In patients who have diabetes and end-stage kidney disease (ESKD), the rates of severe hypoglycemia crises requiring emergency department visits or hospitalizations are the highest so far reported, according to a nationwide study recently published in Diabetes Care. Researchers led by Rodolfo J. Galindo, MD, FACE, associate professor of medicine at Emory University School of...
Share

COVID-19 May Trigger Hyperglycemia and Worsen Disease by Harming Fat Cells

COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study in Cell Metabolism. Researchers led by James C. Lo, MD, PhD, an associate professor of medicine in the Weill Center for Metabolic Health and the Cardiovascular Research Institute at Weill Cornell Medicine and a cardiologist at NewYork-Presbyterian/Weill Cornell Medical Center, found that hyperglycemia is common in hospitalized COVID-19 patients and...
Share

1,5-anhydroglucitol Blood Test More Accurate than HbA1c and Glucose for Predicting Mortality COVID-19 Patients with and without Diabetes

This week, Precision Diabetes, Inc. presented data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate than commonly used diabetes tests in predicting mortality in hospitalized COVID-19 patients with and without diabetes. The study, “1,5-anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19,” was presented at the American Heart Association (AHA) 2021 Scientific...
Share

The Cost of Living (with Diabetes)

100_Years_of_Insulin_Logo A century after its discovery, insulin’s price tag in the U.S. remains alarmingly high for many people living with diabetes. While experts in healthcare and industry have worked with legislators to address the problem, much more needs to be done so that this lifesaving therapy is available to all who need it. When Leonard Thompson’s...